Here is the 17th Most Popular Stock Among 752 Hedge Funds
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Posts Tagged ‘NASDAQ:CELG’
Here is Hedge Funds’ 17th Most Popular Stock Pick
A whopping number of 13F filings filed with U.S.
Hudson Bay Capital Management’s Return, AUM, and Holdings (Part II)
At the end of the first quarter of 2019, Hudson Bay Capital Management held the most valuable stake in Liberty Expedia Holdings, Inc. (NASDAQ:LEXEA), an online travel company.
Hedge Funds Have Never Been This Bullish On Celgene Corporation (CELG)
The market has been volatile in the last 6 months as the Federal Reserve continued its rate hikes and then abruptly reversed its stance and uncertainty looms over trade negotiations...
30 Most Popular Stocks Among Hedge Funds in Q1 of 2019
"By the end of the First Quarter, equity markets had mostly bounced back from Q4 2018’s sharp decline. The dovish shift in Fed policy – which over the last six months went...
Activist Keith Meister Says This Year’s Market Rally and Last December’s Sell-Off Made Us Break Even
In a yesterdays’ CNBC “Squawk Box” program, Corvex Management’s Keith Meister was a guest and he shared his views on the current and the future market state.
Hedge Fund and Insider Trading News: Starboard Value LP, Elliott Management, JMP Group LLC (JMP), TJX Companies Inc (TJX), and More
BOSTON (Reuters) - Activist hedge fund Starboard Value LP said on Friday it will no longer urge shareholders to oppose Bristol-Myers Squibb Co’s plans to buy Celgene Corp, even...
Were Hedge Funds Right About Celgene Corporation (CELG)?
"Market volatility has picked up again over the past few weeks.
Hedge Funds Are Dumping Celgene Corporation (CELG)
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
bluebird bio Inc (BLUE), Iqvia Holdings Inc (IQV): Four Biotech Stocks to Buy Now
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy.
Market Movers Today: Etsy Inc (ETSY), Frontier Communications Corp (FTR), Stratasys Ltd (SSYS), PHH Corporation (PHH), and More
Etsy’s stock price jumped as much as 24% in midday trading on Wednesday, and has now more than doubled from a year ago, thanks to Silverman’s turnaround strategy that got ...
Billionaire Fund Managers Are Bullish On These Biotech Stocks
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Celgene Corporation (CELG): Here’s What Polen Capital Thinks About It
Florida-based Polen Capital sees value in Celgene Corporation (NASDAQ:CELG), which struggled during the past year.
Celgene Corporation (CELG) Offers Compelling Growth Opportunity: Wedgewood
Missouri-based investment firm Wedgewood Partners loves Celgene Corporation (NASDAQ:CELG), an $81-billion global biopharmaceutical company whose shares lost nearly 10% of their...
Netflix, Inc. (NFLX), General Electric Company (GE): Mott Capital Management’s Top Winners and Losers of 2017
Mott Capital Management is a thematic growth fund that was founded in 2014 by Michael J. Kramer. Mr.
13D Filing: Celgene Corp /de/ and Alliqua Biomedical Inc. (NASDAQ:ALQA)
You can access the original SEC filing by clicking here.
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Celgene Corporation (CELG) To Acquire Autoimmune Firm Delinia For $775 Million
Five months ago, Delinia was just a fledgling autoimmune startup with just four full-time staff.
Celgene Corporation (CELG) Eyes Expansion In 2017
Celgene Corporation (NASDAQ:CELG) announced today its 2017 GAAP earnings per share of $5.85–$6.21.
Is It Worth Following Celgene Corporation (CELG) Into Jounce At IPO?
Earlier this year, we looked at a privately held biotech called Jounce Therapeutics.
Is Billionaire Julian Robertson Struggling With Large-Cap Stocks?
Julian Robertson is one of the most scrutinized investors on Wall Street, even though he closed his Tiger Management fund back in 2000.
Celgene Corporation (CELG) Presents Encouraging Phase 2 tnAcity Clinical Trial Results, Decides Not To Pursue Phase 3
Celgene Corporation (NASDAQ:CELG) has recently unveiled the results from the randomized, Phase 2 tnAcity clinical trial evaluating Abraxane for injectable suspension as part of...
Here’s What’s So Important About The bluebird bio Inc (BLUE) Data
bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma (MM) asset, bb2121.
Is Celgene Corporation (CELG) Worthy of Your Portfolio?
Is Celgene Corporation (NASDAQ:CELG) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
What’s Next At GlobeImmune Inc (GBIM)?
GlobeImmune Inc (OTCMKTS:GBIM) shareholders did not have a good week last week.
When Is The PEG Ratio Superior To The P/E Ratio? Part 2
Financial metrics such as P/E ratios, price to cash flow ratios, PEG ratios, price to sales ratios, price to book value, and many others, should be thought of as tools in the ...
Here’s Why Stanley Black & Decker, Celgene Corporation, and Three Other Stocks Are Trending Today
Markets are bearish on Wednesday as investors await minutes from the Federal Open Market Committee’s September meeting, which would likely give an idea about policymakers’ ...
What’s The Deal Between MetaStat Inc. (MTST) And Celgene Corporation (CELG)?
It was back in April when the Chief Medical Officer of pharma giant Celgene Corporation (NASDAQ:CELG), Dr. Jerome B. Zeldis joined the board of MetaStat Inc. (OTCMKTS:MTST).
Eye-Catching Insider Selling at Ross Stores, Celgene Corporation, Copart; Two Other Companies Register Insider Buying
Extensive research shows that corporate insiders tend to make more profit-generating trades than the average non-insider, which serves as the primary reason Insider Monkey, retail...
Why These Five Stocks Are in Spotlight on Monday
Markets inched up before the bell on Monday amid news that recent polls indicated that the British voters are now more inclined towards staying in the EU.
Why Best Buy, Celgene, and Three Other Stocks Are Making Headlines Today
All three index futures are in the green as traders await the Fed's upcoming interest rate decision later today. If rates remain low, the U.S.
Mariner Investment’s Top Healthcare Picks
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant for investing in companies...
Birchview Capital’s Top Healthcare Stock Picks
Birchview Capital is a Vermont-based biosciences-focused long/short equity hedge fund founded by Dr. Matthew Strobeck in 2014. Dr. Strobeck holds a Ph.D.
Here’s Why Investors Are Watching These Five Stocks Today
It's the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on earnings outlooks for the future...
Do Hedge Funds Love Celgene Corporation (CELG)?
Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that ...
Why GoPro, Microsoft, Twitter and Two Other Stocks Are in Spotlight Today
Markets were tumbling on Monday, with all major U.S. stock indexes down substantially, driven by a selloff in tech stocks and a decline in oil prices.
What Has These Companies’ Insiders Cash Out Ahead of 2016?
The insider trading activity was very torpid in the past two holiday-shortened trading weeks, but several companies still witnessed heavy insider selling.
Why Are These Five Stocks Gaining Ground on Wednesday?
Wall Street is rising on Wednesday with all three major indexes trading in the green and shares of Freeport-McMoRan Inc (NYSE:FCX), ArcelorMittal SA (ADR) (NYSE:MT), Celgene Corporation...
Highlights From the 20 Most Popular Stocks Among Financial Advisors
Financial advisors employ considerable resources to identify the best stocks that they could provide advice on to their customers.
Is Celgene Corporation (CELG) A Good Stock To Buy?
Is Celgene Corporation (NASDAQ:CELG) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment...
Mariner Investment Group’s Top Biotech Stock Picks For Q4
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992.
Top Five BioTech Stocks of a Quant Hedge Fund
Massachusetts-based Arrowstreet Capital recently has issued its latest 13F filing with the Securities and Exchange Commission for the reporting quarter ended September 30.
Sivik Global Healthcare’s Top Biotech Stock Picks For Q4
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006.
Are Beech Hill Advisors’ Top Biotech Stock Picks Poised For A Big Q4?
Beech Hill Advisors is a New York-based registered investment advisor founded by Paul Cantor and Joseph Weiss in 1987. Mr.
Did Analysts Get One Of These Upgrades Wrong?
Three notable companies were given upgrades by analysts this morning, mostly due to recent weakness in the price of their shares (but then, few stocks have been able to escape...
Silver Arrow’s Top Long Positions: Facebook Inc (FB), Celgene Corporation (CELG), Hertz Global Holdings Inc (HTZ), More
Silver Arrow Partners, L.P, a New York-based fund, reported returns of 1.04% for the second quarter of 2015 along with year-to-date returns of 0.75% in its recently released ...
Hedge Fund Were Wrong About Receptos Inc (RCPT) As Celgene Corporation (CELG) Snatches It Up At Premium
The shares of both Receptos Inc (NASDAQ:RCPT) and Celgene Corporation (NASDAQ:CELG) are trading 10% higher after the two pharmaceutical companies entered into a definitive merger...
Apple Inc. (AAPL), Southwest Airlines Co (LUV), McDonald’s Corporation (MCD) Among Long-Term Stock Holdings of Peak6 Investments
Matthew Hulsizer's Peak6 Investments, L.P. has filed its 13F with the SEC for the reporting period of March 31.
Stevens Capital’s Top New Stock Picks Include Celgene Corporation (CELG), Chipotle Mexican Grill, Inc. (CMG)
Matthew Tewksbury's Stevens Capital Management has disclosed its equity holdings in a 13F filing with the SEC for the reporting period of March 31.
